Page last updated: 2024-09-03

omega-n-methylarginine and Migraine Disorders

omega-n-methylarginine has been researched along with Migraine Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Al-Hassany, L; Boersma, E; Danser, AHJ; Fauser, BCJM; Laven, JSE; Linstra, KM; Maassen Van Den Brink, A; Meun, C; Terwindt, GM; van den Berg, J; Wermer, MJH1
de Hoon, JN; Vanmolkot, FH1
Christiansen, I; Iversen, HK; Jansen-Olesen, I; Lassen, LH; Olesen, J1
Ashina, M; Christiansen, I; Lassen, LH; Olesen, J; Ulrich, V1
Ashina, M; Christiansen, I; Donaldson, J; Grover, R; Lassen, LH; Olesen, J; Ulrich, V1
Láinez, MJ; Monzón, MJ1

Reviews

1 review(s) available for omega-n-methylarginine and Migraine Disorders

ArticleYear
Chronic daily headache.
    Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2

    Topics: Adolescent; Adult; Aged; Analgesics; Botulinum Toxins, Type A; Clinical Trials as Topic; Comorbidity; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Headache Disorders; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase; Nociceptors; omega-N-Methylarginine; Prognosis; Substance Withdrawal Syndrome; Substance-Related Disorders; Tension-Type Headache; Tomography, Emission-Computed; Trigeminal Nerve

2001

Trials

3 trial(s) available for omega-n-methylarginine and Migraine Disorders

ArticleYear
The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs.
    Cephalalgia : an international journal of headache, 2003, Volume: 23, Issue:9

    Topics: Adult; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Histamine; Humans; Male; Middle Aged; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Organ Culture Techniques; Radial Artery; Time Factors; Vasodilation

2003
Nitric oxide synthase inhibition in migraine.
    Lancet (London, England), 1997, Feb-08, Volume: 349, Issue:9049

    Topics: Adolescent; Adult; Double-Blind Method; Humans; Infusions, Intravenous; Middle Aged; Migraine Disorders; Nitric Oxide Synthase; omega-N-Methylarginine

1997
Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks.
    Cephalalgia : an international journal of headache, 1998, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Migraine Disorders; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome

1998

Other Studies

2 other study(ies) available for omega-n-methylarginine and Migraine Disorders

ArticleYear
Decreased role of neuropeptides in the microvascular function in migraine patients with polycystic ovary syndrome.
    Atherosclerosis, 2023, Volume: 384

    Topics: Female; Humans; Middle Aged; Migraine Disorders; omega-N-Methylarginine; Polycystic Ovary Syndrome; Risk Factors; Vasodilation

2023
Endothelial function in migraine: a cross-sectional study.
    BMC neurology, 2010, Dec-01, Volume: 10

    Topics: Adult; Analysis of Variance; Cross-Sectional Studies; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Forearm; Humans; Male; Migraine Disorders; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Substance P; Tissue Plasminogen Activator; Vasodilation

2010